Providence and Boston Team Represents Juvenescence Limited in BYOMass Investment

A Locke Lord team led by Douglas Gray (Providence) represented Juvenescence Limited, a leading drug development company based in the British Virgin Islands and focused on the development of therapies to increase human longevity, in connection with its latest investment in BYOMass Inc., a Massachusetts-based company focused on developing treatments for obesity and cachexia. Juvenescence will support BYOMass with up to $6.5 million in equity financing, in addition to its therapy and drug development capabilities. Additional team members included Lori Basilico (Providence), Richard Glovsky and Ralph Loren (both of Boston).
Posted on April 1, 2019